drugset / Trial / NCT03830320

Positron Emission Tomography (PET) Imaging of Thrombosis

NCT03830320 ↗

Non-randomizedSingle-groupOpen-labelDiagnostic

Summary

The purpose of the study is to evaluate a new radiotracer called 64Cu-FBP8 for PET-MR imaging of thrombosis. The tracer has the potential of detecting thrombosis anywhere in the body, for instance in the left atrial appendage of patients with atrial fibrillation, and thereby may provide a non-invasive alternative to the current standard-of-care methods.

Timeline

Start
2016-04-01
Primary completion
2027-01-31
Completion
2027-01-31

Drugs

EvaluationDrugModalityDoseRoute
Subject 64Cu-FBP8 Diagnostic / imaging agent — —